Signaling of gp34 (OX40 ligand) induces vascular endothelial cells to produce a CC chemokine RANTES/CCL5

被引:57
作者
Kotani, A [1 ]
Hori, T [1 ]
Matsumura, Y [1 ]
Uchiyama, T [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068507, Japan
关键词
OX40; gp34; RANTES/CCL5; cDNA array; HUVEC;
D O I
10.1016/S0165-2478(02)00082-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We previously showed that gp34 (OX40 ligand) expressed on vascular endothelial cells is not only involved in adhesion between activated T cells and endothelial cells but also by itself able to transmit intracellular signals leading to expression of c-fos and c-jun mRNA upon OX40 binding. In the present study, we searched for genes that were induced or upregulated by gp34 signaling in human umbilical vein endothelial cells (HUVECs) to define its downstream biological events. HUVECs expressing high levels of gp34 were stimulated with recombinant soluble OX40 or mock control and subjected to analysis using cDNA expression arrays. We found that a CC chemokine RANTES (regulated upon activation, normal T cell expressed and secreted)/CCL5 is one of such inducible genes. Reverse transcriptase-PCR analysis showed that expression of RANTES mRNA was induced after incubation with soluble OX40 and this induction was inhibited by anti-gp34 mAb. We could detect expression of intracellular RANTES protein by flow cytometry in HUVECs stimulated with soluble OX40 as well as fixed OX40 transfectant cells but not those stimulated with mock supernatants or mock transfectant cells. Again, this induction of RANTES protein was inhibited by anti-gp34 mAb. These results clearly indicate that gp34 signaling induces expression of RANTES at both mRNA and protein levels in HUVECs and suggest a possible link between the OX40/gp34 system and RANTES during the process of T cell adhesion to endothelial cells and subsequent extravasation. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 41 条
[21]   Localization of OX40/gp34 in inflammatory skin diseases: a clue to elucidate the interaction between activated T cells and endothelial cells in infiltration [J].
Matsumura, Y ;
Imura, A ;
Hori, T ;
Uchiyama, T ;
Imamura, S .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1997, 289 (11) :653-656
[22]   Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion [J].
Maxwell, JR ;
Weinberg, A ;
Prell, RA ;
Vella, AT .
JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :107-112
[23]   MOLECULAR-CLONING AND CHARACTERIZATION OF A NOVEL GLYCOPROTEIN, GP34, THAT IS SPECIFICALLY INDUCED BY THE HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I TRANSACTIVATOR P40TAX [J].
MIURA, S ;
OHTANI, K ;
NUMATA, N ;
NIKI, M ;
OHBO, K ;
INA, Y ;
GOJOBORI, T ;
TANAKA, Y ;
TOZAWA, H ;
NAKAMURA, M ;
SUGAMURA, K .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (03) :1313-1325
[24]   Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantation [J].
Monti, G ;
Magnan, A ;
Fattal, M ;
Rain, B ;
Humbert, M ;
Mege, JL ;
Noirclerc, M ;
Dartevelle, P ;
Cerrina, J ;
Simonneau, G ;
Galanaud, P ;
Emilie, D .
TRANSPLANTATION, 1996, 61 (12) :1757-1762
[25]   CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses [J].
Morimoto, S ;
Kanno, Y ;
Tanaka, Y ;
Tokano, Y ;
Hashimoto, H ;
Jacquot, S ;
Morimoto, C ;
Schlossman, SF ;
Yagita, H ;
Okumura, K ;
Kobata, T .
JOURNAL OF IMMUNOLOGY, 2000, 164 (08) :4097-4104
[26]   Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations [J].
Mura, P ;
Faucci, MT ;
Bramanti, G ;
Corti, P .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 9 (04) :365-372
[27]   Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis [J].
Ndhlovu, LC ;
Ishii, N ;
Murata, K ;
Sato, T ;
Sugamura, K .
JOURNAL OF IMMUNOLOGY, 2001, 167 (05) :2991-2999
[28]   Amelioration of experimental autoimmune encephalomyelitis with Anti-OX40 ligand monoclonal antibody: A critical role for OX40 ligand in migration, but not development, of pathogenic T cells [J].
Nohara, C ;
Akiba, H ;
Nakajima, A ;
Inoue, A ;
Koh, CS ;
Ohshima, H ;
Yagita, H ;
Mizuno, Y ;
Okumura, K .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :2108-2115
[29]  
Ohshima Y, 1997, J IMMUNOL, V159, P3838
[30]   OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells [J].
Rogers, PR ;
Song, JX ;
Gramaglia, I ;
Killeen, N ;
Croft, M .
IMMUNITY, 2001, 15 (03) :445-455